← Evidence map

ReviewCellular & molecular biology letters2022

CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool.

Sadegh Shojaei Baghini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35508982